Literature DB >> 10389930

Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds.

S Iida1, Y Akiyama, W Ichikawa, T Yamashita, T Nomizu, Z Nihei, K Sugihara, Y Yuasa.   

Abstract

Germ-line mutation of the E-cadherin gene was reported in familial gastric cancer (FGC) kindreds from New Zealand. Therefore, we analyzed all of the exons of E-cadherin by PCR-single-strand conformational polymorphism analysis in 16 patients from 14 Japanese FGC kindreds. However, no germ-line mutation was detected, suggesting that a predisposition to FGCs by E-cadherin gene mutation is infrequent in Japanese cases.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10389930

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  10 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  CDH1/E-cadherin germline mutations in early-onset gastric cancer.

Authors:  J T Bacani; M Soares; R Zwingerman; N di Nicola; J Senz; R Riddell; D G Huntsman; S Gallinger
Journal:  J Med Genet       Date:  2006-06-26       Impact factor: 6.318

3.  Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer.

Authors:  Hyuk-Joon Lee; Hye Seung Lee; Keun Hur; Woo Ho Kim; Kazuyoshi Yanagihara; Karl-Friedrich Becker; Kuhn Uk Lee; Han-Kwang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-19       Impact factor: 4.553

4.  Genetic screening for familial gastric cancer.

Authors:  Carla Oliveira; Gianpaolo Suriano; Paulo Ferreira; Paulo Canedo; Pardeep Kaurah; Rita Mateus; Ana Ferreira; António C Ferreira; Maria José Oliveira; Céu Figueiredo; Fátima Carneiro; Gisela Keller; David Huntsman; José Carlos Machado; Raquel Seruca
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

5.  A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome.

Authors:  Il-Jin Kim; Hio Chung Kang; Yong Shin; Hye-Won Park; Sang-Geun Jang; Song-Yee Han; Sun-Kyung Lim; Min Ro Lee; Hee Jin Chang; Ja-Lok Ku; Han-Kwang Yang; Jae-Gahb Park
Journal:  J Hum Genet       Date:  2004-09-10       Impact factor: 3.172

6.  Low frequency of E-cadherin alterations in familial breast cancer.

Authors:  S Salahshor; L Haixin; H Huo; V N Kristensen; N Loman; S Sjöberg-Margolin; A Borg ; A L Børresen-Dale; I Vorechovsky; A Lindblom
Journal:  Breast Cancer Res       Date:  2001-03-09       Impact factor: 6.466

7.  Absence of germline CHK2 mutations in familial gastric cancer.

Authors:  K Kimura; K Shinmura; K Yoshimura; K Shimizu; H Katai; Y Beppu; H Moriya; J Yokota
Journal:  Jpn J Cancer Res       Date:  2000-09

8.  Defined lifestyle and germline factors predispose Asian populations to gastric cancer.

Authors:  Akihiro Suzuki; Hiroto Katoh; Daisuke Komura; Miwako Kakiuchi; Amane Tagashira; Shogo Yamamoto; Kenji Tatsuno; Hiroki Ueda; Genta Nagae; Shiro Fukuda; Takayoshi Umeda; Yasushi Totoki; Hiroyuki Abe; Tetsuo Ushiku; Tetsuya Matsuura; Eiji Sakai; Takashi Ohshima; Sachiyo Nomura; Yasuyuki Seto; Tatsuhiro Shibata; Yasushi Rino; Atsushi Nakajima; Masashi Fukayama; Shumpei Ishikawa; Hiroyuki Aburatani
Journal:  Sci Adv       Date:  2020-05-06       Impact factor: 14.136

9.  Gastric adenocarcinoma presenting with gastric outlet obstruction in a child.

Authors:  Abdulrahman Al-Hussaini; Salem Alghamdi; Rasha Alsaaran; Fawaz Al-Kasim; Zakaria Habib; Nouri Ourfali
Journal:  Case Rep Gastrointest Med       Date:  2014-01-14

Review 10.  Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations.

Authors:  Hiroto Katoh; Shumpei Ishikawa
Journal:  J Hum Genet       Date:  2021-07-16       Impact factor: 3.172
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.